Back

Reduction in the risk of major adverse limb events with ezetimibe versus placebo in addition to statin therapy: insights from the IMPROVE IT trial

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Arterial occlusive disease: a chronic pandemic needing attention to detail Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

8 More presentations in this session

Presentation thumbnail
Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease
Doctor M. Bonaca (Aurora, US)
Abstract Slides Video
Presentation thumbnail
The impact of Covid-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 2020
Professor C. Hehrlein (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Association between electronic nicotine delivery systems use and risk of stroke: A systematic review and meta-analysis of observational studies with 822,162 participants.
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Olive extract enriched with hydroxytyrosol improves cardiac and vascular function in patients with stable coronary artery disease: a double-blind, placebo-controlled trial.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Of mice and men: transcriptome-based clustering reveals molecular heterogeneity among mouse atherosclerosis models and partially reflects the diversity of human plaques
Mr E. Brouwer (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Arterial occlusive disease: a chronic pandemic needing attention to detail

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources